MLKL_HUMAN - dbPTM
MLKL_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MLKL_HUMAN
UniProt AC Q8NB16
Protein Name Mixed lineage kinase domain-like protein
Gene Name MLKL {ECO:0000312|EMBL:AAH28141.1}
Organism Homo sapiens (Human).
Sequence Length 471
Subcellular Localization Cytoplasm . Cell membrane . Localizes to the cytoplasm and translocates to the plasma membrane on necroptosis induction.
Protein Description Pseudokinase that plays a key role in TNF-induced necroptosis, a programmed cell death process. Activated following phosphorylation by RIPK3, leading to homotrimerization, localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage. Does not have protein kinase activity..
Protein Sequence MENLKHIITLGQVIHKRCEEMKYCKKQCRRLGHRVLGLIKPLEMLQDQGKRSVPSEKLTTAMNRFKAALEEANGEIEKFSNRSNICRFLTASQDKILFKDVNRKLSDVWKELSLLLQVEQRMPVSPISQGASWAQEDQQDADEDRRAFQMLRRDNEKIEASLRRLEINMKEIKETLRQYLPPKCMQEIPQEQIKEIKKEQLSGSPWILLRENEVSTLYKGEYHRAPVAIKVFKKLQAGSIAIVRQTFNKEIKTMKKFESPNILRIFGICIDETVTPPQFSIVMEYCELGTLRELLDREKDLTLGKRMVLVLGAARGLYRLHHSEAPELHGKIRSSNFLVTQGYQVKLAGFELRKTQTSMSLGTTREKTDRVKSTAYLSPQELEDVFYQYDVKSEIYSFGIVLWEIATGDIPFQGCNSEKIRKLVAVKRQQEPLGEDCPSELREIIDECRAHDPSVRPSVDEILKKLSTFSK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
16AcetylationTLGQVIHKRCEEMKY
HHHHHHHHHHHHHHH
47.8526051181
22UbiquitinationHKRCEEMKYCKKQCR
HHHHHHHHHHHHHHH
51.2624816145
40UbiquitinationHRVLGLIKPLEMLQD
HHHHHHHHHHHHHHH
48.9029967540
50UbiquitinationEMLQDQGKRSVPSEK
HHHHHCCCCCCCHHH
35.5533845483
52PhosphorylationLQDQGKRSVPSEKLT
HHHCCCCCCCHHHHH
41.6923403867
55PhosphorylationQGKRSVPSEKLTTAM
CCCCCCCHHHHHHHH
45.2523403867
57UbiquitinationKRSVPSEKLTTAMNR
CCCCCHHHHHHHHHH
56.3124816145
59PhosphorylationSVPSEKLTTAMNRFK
CCCHHHHHHHHHHHH
24.4723403867
60PhosphorylationVPSEKLTTAMNRFKA
CCHHHHHHHHHHHHH
34.0523403867
66AcetylationTTAMNRFKAALEEAN
HHHHHHHHHHHHHHC
29.5226051181
66UbiquitinationTTAMNRFKAALEEAN
HHHHHHHHHHHHHHC
29.5229967540
78UbiquitinationEANGEIEKFSNRSNI
HHCCHHHHHCCCCCH
60.8129967540
92PhosphorylationICRFLTASQDKILFK
HHHHHHCCCCCEEHH
33.4125159151
95AcetylationFLTASQDKILFKDVN
HHHCCCCCEEHHHHC
33.4025953088
106PhosphorylationKDVNRKLSDVWKELS
HHHCHHHHHHHHHHH
32.9020873877
125PhosphorylationVEQRMPVSPISQGAS
HHHHCCCCCCCCCCC
15.6225159151
128PhosphorylationRMPVSPISQGASWAQ
HCCCCCCCCCCCHHH
26.4121815630
132PhosphorylationSPISQGASWAQEDQQ
CCCCCCCCHHHHHHC
29.7522468782
157UbiquitinationMLRRDNEKIEASLRR
HHHHCHHHHHHHHHH
52.6929967540
157AcetylationMLRRDNEKIEASLRR
HHHHCHHHHHHHHHH
52.6925953088
161PhosphorylationDNEKIEASLRRLEIN
CHHHHHHHHHHHHCC
15.0429514088
173UbiquitinationEINMKEIKETLRQYL
HCCHHHHHHHHHHHC
45.8229967540
183UbiquitinationLRQYLPPKCMQEIPQ
HHHHCCHHHHCCCCH
40.1629967540
198UbiquitinationEQIKEIKKEQLSGSP
HHHHHHHHHHHCCCC
57.2529967540
215PhosphorylationLLRENEVSTLYKGEY
EEECCCCCCCCCCCC
13.4030108239
216PhosphorylationLRENEVSTLYKGEYH
EECCCCCCCCCCCCC
39.0030108239
218PhosphorylationENEVSTLYKGEYHRA
CCCCCCCCCCCCCCC
19.6230108239
219UbiquitinationNEVSTLYKGEYHRAP
CCCCCCCCCCCCCCC
48.6729967540
222PhosphorylationSTLYKGEYHRAPVAI
CCCCCCCCCCCCHHH
12.7930108239
230UbiquitinationHRAPVAIKVFKKLQA
CCCCHHHHHHHHCCC
31.7029967540
246PhosphorylationSIAIVRQTFNKEIKT
CEEEEEHHHCHHHHH
20.7220393185
249UbiquitinationIVRQTFNKEIKTMKK
EEEHHHCHHHHHHHH
57.5429967540
253O-linked_GlycosylationTFNKEIKTMKKFESP
HHCHHHHHHHHCCCC
39.6329237092
259O-linked_GlycosylationKTMKKFESPNILRIF
HHHHHCCCCCHHHEE
26.7829237092
302PhosphorylationLDREKDLTLGKRMVL
HHHHCCCCHHHHHHH
43.53-
331UbiquitinationEAPELHGKIRSSNFL
CCHHHCCEEECCCEE
24.9733845483
334PhosphorylationELHGKIRSSNFLVTQ
HHCCEEECCCEEEEC
32.86-
354AcetylationLAGFELRKTQTSMSL
ECCEEEECCCCCCCC
58.577377595
354UbiquitinationLAGFELRKTQTSMSL
ECCEEEECCCCCCCC
58.5724816145
357PhosphorylationFELRKTQTSMSLGTT
EEEECCCCCCCCCCC
31.4622265413
357O-linked_GlycosylationFELRKTQTSMSLGTT
EEEECCCCCCCCCCC
31.4629237092
358O-linked_GlycosylationELRKTQTSMSLGTTR
EEECCCCCCCCCCCH
9.1429237092
358PhosphorylationELRKTQTSMSLGTTR
EEECCCCCCCCCCCH
9.1422265413
360PhosphorylationRKTQTSMSLGTTREK
ECCCCCCCCCCCHHH
24.34-
364PhosphorylationTSMSLGTTREKTDRV
CCCCCCCCHHHCHHC
34.72-
367UbiquitinationSLGTTREKTDRVKST
CCCCCHHHCHHCCCC
53.0522817900
372UbiquitinationREKTDRVKSTAYLSP
HHHCHHCCCCEECCH
42.8721963094
373PhosphorylationEKTDRVKSTAYLSPQ
HHCHHCCCCEECCHH
18.5323663014
374PhosphorylationKTDRVKSTAYLSPQE
HCHHCCCCEECCHHH
17.3819276368
376PhosphorylationDRVKSTAYLSPQELE
HHCCCCEECCHHHHH
14.0623663014
378PhosphorylationVKSTAYLSPQELEDV
CCCCEECCHHHHHHH
16.3223663014
387PhosphorylationQELEDVFYQYDVKSE
HHHHHHHHHCCCCHH
13.1526074081
389PhosphorylationLEDVFYQYDVKSEIY
HHHHHHHCCCCHHEE
16.0126074081
393PhosphorylationFYQYDVKSEIYSFGI
HHHCCCCHHEEEEEE
29.1326074081
396PhosphorylationYDVKSEIYSFGIVLW
CCCCHHEEEEEEEEE
8.2226074081
397PhosphorylationDVKSEIYSFGIVLWE
CCCHHEEEEEEEEEE
23.7426074081
407PhosphorylationIVLWEIATGDIPFQG
EEEEEHHCCCCCCCC
40.8426074081
417PhosphorylationIPFQGCNSEKIRKLV
CCCCCCCHHHHHHHH
44.3226074081
454PhosphorylationECRAHDPSVRPSVDE
HHHHCCCCCCCCHHH
36.4920873877
458PhosphorylationHDPSVRPSVDEILKK
CCCCCCCCHHHHHHH
31.4720873877
467PhosphorylationDEILKKLSTFSK---
HHHHHHHHCCCC---
35.9623312004
468PhosphorylationEILKKLSTFSK----
HHHHHHHCCCC----
42.2223312004
470PhosphorylationLKKLSTFSK------
HHHHHCCCC------
37.2323312004

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
357TPhosphorylationKinaseRIPK3Q9Y572
Uniprot
358SPhosphorylationKinaseRIPK3Q9Y572
Uniprot
360SPhosphorylationKinaseRIPK3Q9Y572
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MLKL_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MLKL_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NDUB7_HUMANNDUFB7physical
21988832
RAD18_HUMANRAD18physical
21988832
THOC3_HUMANTHOC3physical
21988832
CASP8_HUMANCASP8physical
26496610
GSLG1_HUMANGLG1physical
26496610
SRA1_HUMANSRA1physical
26496610
PAR16_HUMANPARP16physical
26496610
LRCH3_HUMANLRCH3physical
26496610
TRAF2_HUMANTRAF2physical
25882049
RIPK1_HUMANRIPK1physical
27560715
RIPK3_HUMANRIPK3physical
27560715

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MLKL_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND MASSSPECTROMETRY.

TOP